PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 153 filers reported holding PROTAGONIST THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.62 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,465,771 | -17.0% | 147,828 | +37.5% | 0.00% | 0.0% |
Q2 2023 | $2,969,730 | -40.7% | 107,521 | -50.6% | 0.00% | -33.3% |
Q1 2023 | $5,008,227 | +210.0% | 217,749 | +47.1% | 0.00% | +200.0% |
Q4 2022 | $1,615,422 | -39.2% | 148,068 | -53.0% | 0.00% | -50.0% |
Q3 2022 | $2,657,000 | +5.8% | 315,194 | -0.7% | 0.00% | 0.0% |
Q2 2022 | $2,511,000 | +197.5% | 317,499 | +790.5% | 0.00% | +100.0% |
Q1 2022 | $844,000 | -82.1% | 35,656 | -74.1% | 0.00% | -66.7% |
Q4 2021 | $4,711,000 | +419.4% | 137,751 | +169.1% | 0.00% | +200.0% |
Q3 2021 | $907,000 | -72.1% | 51,185 | -29.4% | 0.00% | -50.0% |
Q2 2021 | $3,256,000 | +31.3% | 72,540 | -24.2% | 0.00% | 0.0% |
Q1 2021 | $2,479,000 | +1164.8% | 95,720 | +886.1% | 0.00% | – |
Q4 2020 | $196,000 | +317.0% | 9,707 | +302.6% | 0.00% | – |
Q3 2020 | $47,000 | -95.9% | 2,411 | -96.3% | 0.00% | -100.0% |
Q2 2020 | $1,140,000 | +2180.0% | 64,547 | +819.2% | 0.00% | – |
Q1 2020 | $50,000 | +25.0% | 7,022 | +24.5% | 0.00% | – |
Q4 2019 | $40,000 | +400.0% | 5,639 | +709.0% | 0.00% | – |
Q3 2019 | $8,000 | -84.0% | 697 | -83.0% | 0.00% | – |
Q2 2019 | $50,000 | -84.3% | 4,107 | -83.8% | 0.00% | – |
Q1 2019 | $319,000 | +275.3% | 25,351 | +99.7% | 0.00% | – |
Q2 2018 | $85,000 | +400.0% | 12,697 | +536.4% | 0.00% | – |
Q1 2018 | $17,000 | -52.8% | 1,995 | +14.0% | 0.00% | – |
Q4 2017 | $36,000 | +3500.0% | 1,750 | +2677.8% | 0.00% | – |
Q2 2017 | $1,000 | -50.0% | 63 | -56.2% | 0.00% | – |
Q1 2017 | $2,000 | -98.8% | 144 | -98.1% | 0.00% | – |
Q4 2016 | $168,000 | +1192.3% | 7,644 | +1130.9% | 0.00% | – |
Q3 2016 | $13,000 | – | 621 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JOHNSON & JOHNSON | 2,449,183 | $19,373,000 | 4.95% |
Bain Capital Life Sciences Investors, LLC | 2,260,572 | $17,881,000 | 2.10% |
Finepoint Capital LP | 735,126 | $5,815,000 | 2.01% |
Altium Capital Management LP | 365,100 | $2,888,000 | 1.16% |
RTW INVESTMENTS, LP | 4,794,499 | $37,924,000 | 0.98% |
Amitell Capital Pte Ltd | 50,129 | $397,000 | 0.90% |
COWEN AND COMPANY, LLC | 1,065,724 | $8,430,000 | 0.81% |
Tri Locum Partners LP | 155,000 | $1,226,000 | 0.50% |
BVF INC/IL | 1,106,838 | $8,755,000 | 0.42% |
HighVista Strategies LLC | 46,459 | $367,000 | 0.22% |